Toshinori Murata Selected Research

Cataract (Cataracts)

3/2023	Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema.
10/2022	Temporal Change in Anterior Chamber Depth after Combined Vitrectomy and Cataract Surgery Using Different Sizes of Intraocular Lens.
6/2022	Optical coherence tomography angiography findings before and after onset of foveal retinal neovascularization in diabetic retinopathy.
1/2014	Multicolor pattern scan laser for diabetic retinopathy with cataract.
1/2014	Effect of Laser wavelength on delivering appropriate laser burns through the opaque lens using a pattern scan laser.
5/2006	Rubeosis iridis after bilateral cataract surgery and its spontaneous regression in a patient with myotonic dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshinori Murata Research Topics

Disease

16	Macular Edema 12/2023 - 02/2006
11	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2023 - 01/2014
10	Retinal Vein Occlusion 10/2022 - 11/2008
7	Amyloidosis 01/2023 - 01/2007
7	Glaucoma 01/2023 - 01/2007
6	Macular Degeneration (Age-Related Maculopathy) 03/2023 - 12/2008
6	Cataract (Cataracts) 03/2023 - 05/2006
5	Polypoidal Choroidal Vasculopathy 03/2023 - 12/2008
5	Transthyretin-Related Hereditary Amyloidosis 01/2023 - 01/2020
4	Ischemia 12/2022 - 06/2013
4	Microaneurysm 01/2019 - 01/2007
3	Inflammation (Inflammations) 03/2023 - 05/2017
3	Amyloid angiopathy 01/2023 - 01/2022
3	Choroidal Neovascularization 01/2023 - 06/2015
3	Edema (Dropsy) 01/2021 - 01/2017
3	Retinal Detachment (Retinal Detachments) 03/2018 - 01/2014
2	Vision Disorders (Hemeralopia) 03/2023 - 12/2021
2	Fibrosis (Cirrhosis) 01/2023 - 01/2021
2	Vascular Diseases (Vascular Disease) 01/2022 - 06/2015
2	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 09/2020 - 01/2007
2	Atrophy 05/2020 - 01/2019
2	Hemorrhage 01/2019 - 07/2011
2	Mydriasis 12/2018 - 01/2014
2	Burns 01/2014 - 01/2014
2	Retinal Degeneration 06/2009 - 05/2002
1	Vasculitis (Vasculitides) 03/2023
1	Retinal Vasculitis 03/2023
1	Corneal Injuries 01/2023
1	Astigmatism 01/2023
1	Cicatrix (Scar) 01/2023
1	Coma (Comas) 01/2023
1	Immunoglobulin Light-chain Amyloidosis 10/2022
1	Retinal Neovascularization 06/2022
1	Familial Amyloidosis (Hereditary Amyloidosis) 10/2021
1	Tonic Pupil 09/2021
1	Photophobia (Light Sensitivity) 09/2021
1	Posterior Uveitis 09/2021
1	Uveitis 09/2021
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2021
1	Papilledema 05/2020
1	Thrombosis (Thrombus) 01/2019
1	Polyps 11/2018
1	Fat Embolism 07/2016
1	Scotoma (Scintillating Scotoma) 07/2016
1	Pathologic Neovascularization 01/2016

Drug/Important Bio-Agent (IBA)

26	Retinaldehyde (Retinal)IBA 03/2023 - 05/2002
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 03/2016
8	Fluorescein (Funduscein)FDA LinkGeneric 03/2023 - 06/2015
7	Prealbumin (Transthyretin)IBA 01/2023 - 09/2020
7	Ranibizumab (Lucentis)FDA Link 10/2022 - 03/2016
5	afliberceptIBA 03/2023 - 01/2017
5	AdrenomedullinIBA 01/2023 - 01/2008
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023 - 11/2018
3	Peptides (Polypeptides)IBA 01/2021 - 01/2008
2	faricimabIBA 12/2023 - 09/2023
2	Triamcinolone (Aristocort)FDA Link 03/2023 - 07/2004
2	brolucizumabIBA 03/2023 - 01/2023
2	Ophthalmic Solutions (Eye Drops)IBA 03/2023 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2012
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2007
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2007
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2018 - 12/2008
2	Advanced Glycation End ProductsIBA 09/2014 - 12/2007
1	Angiopoietin-2IBA 12/2023
1	SteroidsIBA 03/2023
1	Betamethasone (Celestone)FDA Link 03/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023
1	Sulfur HexafluorideIBA 10/2022
1	N-acetyltryptophanamide (NATA)IBA 12/2021
1	Retinal Pigments (Pigments, Visual)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	CXC ChemokinesIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	Adrenomedullin ReceptorsIBA 01/2021
1	Receptor Activity-Modifying Protein 2IBA 01/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 09/2020
1	Therapeutic UsesIBA 05/2020
1	Rose BengalIBA 01/2019
1	isothiocyanic acidIBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 11/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Pregnenolone Carbonitrile (PCN)IBA 03/2016
1	AcidsIBA 01/2016

Therapy/Procedure

17	Lasers (Laser) 01/2023 - 01/2014
10	Vitrectomy 01/2023 - 07/2004
9	Light Coagulation 03/2023 - 01/2007
5	Injections 03/2023 - 03/2016
5	Trabeculectomy (Trabeculoplasty) 01/2023 - 01/2007
5	Therapeutics 01/2023 - 01/2017
4	Intravitreal Injections 01/2023 - 01/2017
2	Aftercare (After-Treatment) 09/2021 - 05/2021
2	Photochemotherapy (Photodynamic Therapy) 11/2018 - 12/2008
1	Percutaneous Collagen Induction 01/2023
1	Surgical Instruments (Clip) 01/2023
1	Sutures (Suture) 01/2023
1	Liver Transplantation 01/2023
1	Intraocular Lenses (Intraocular Lens) 10/2022
1	Glaucoma Drainage Implants 09/2020